Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BICX OTCMKTS:GRST NASDAQ:MGRX NYSE:SSY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBICXBiocorrx$0.35$0.39$0.20▼$1.45$6.62M0.1330 shsN/AGRSTEthema Health$0.00$0.00$0.00▼$0.00$2.32M1.91264,385 shsN/AMGRXMangoceuticals$1.73+4.2%$1.68$1.32▼$7.66$18.23M2.4282,378 shs101,857 shsSSYSunLink Health Systems$1.12+16.6%$1.04$0.62▼$1.91$7.88M1.16145,367 shs243,934 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBICXBiocorrx0.00%-14.51%-18.28%+16.67%+24.11%GRSTEthema Health0.00%0.00%0.00%-25.00%-66.67%MGRXMangoceuticals0.00%+5.49%-1.14%+2.37%-97.33%SSYSunLink Health Systems0.00%0.00%-8.28%+31.65%+37.30%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBICXBiocorrxN/AN/AN/AN/AN/AN/AN/AN/AGRSTEthema HealthN/AN/AN/AN/AN/AN/AN/AN/AMGRXMangoceuticals0.7038 of 5 stars0.02.00.00.02.51.70.6SSYSunLink Health SystemsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBICXBiocorrx 0.00N/AN/AN/AGRSTEthema Health 0.00N/AN/AN/AMGRXMangoceuticals 0.00N/AN/AN/ASSYSunLink Health Systems 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBICXBiocorrx$10K661.85N/AN/A($0.69) per share-0.51GRSTEthema Health$6.02M0.39N/AN/AN/A∞MGRXMangoceuticals$620K29.41N/AN/A$1.83 per share0.95SSYSunLink Health Systems$31.09M0.25N/AN/A$2.27 per share0.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBICXBiocorrx-$5.11M-$0.35N/A∞N/AN/AN/A-130.26%11/12/2025 (Estimated)GRSTEthema Health-$2.06MN/A0.00∞N/A-1.03%N/A-0.51%N/AMGRXMangoceuticals-$8.71M-$3.86N/A∞N/A-2,757.86%-85.01%-78.08%N/ASSYSunLink Health Systems-$1.53M$0.244.66∞N/A5.55%-18.98%-14.79%N/ALatest GRST, MGRX, SSY, and BICX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025BICXBiocorrxN/A-$0.07N/A-$0.07N/A$0.18 million8/14/2025Q2 2025MGRXMangoceuticalsN/A-$0.57N/A-$0.57N/A$0.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBICXBiocorrxN/AN/AN/AN/AN/AGRSTEthema HealthN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/ASSYSunLink Health SystemsN/AN/AN/AN/AN/ALatest GRST, MGRX, SSY, and BICX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/21/2025SSYSunLink Health Systemsspecial$0.107/29/20257/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBICXBiocorrxN/A0.040.03GRSTEthema HealthN/A0.050.05MGRXMangoceuticalsN/A0.070.12SSYSunLink Health SystemsN/A3.913.50Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBICXBiocorrxN/AGRSTEthema HealthN/AMGRXMangoceuticals56.72%SSYSunLink Health Systems23.67%Insider OwnershipCompanyInsider OwnershipBICXBiocorrx21.40%GRSTEthema Health55.75%MGRXMangoceuticals16.00%SSYSunLink Health Systems27.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBICXBiocorrx318.91 million14.87 millionNot OptionableGRSTEthema Health507.73 billion3.42 billionNot OptionableMGRXMangoceuticals310.54 million8.85 millionNot OptionableSSYSunLink Health Systems1,3767.04 million5.08 millionNot OptionableGRST, MGRX, SSY, and BICX HeadlinesRecent News About These CompaniesSunlink Health Systems Completes Merger with Regional HealthAugust 14, 2025 | msn.comRegional Health Properties, Inc. and SunLink Health Systems, Inc. ...August 4, 2025 | gurufocus.comRegional Health Properties, Inc. and SunLink Health Systems, Inc. Announce Receipt of Shareholder Approvals for MergerAugust 4, 2025 | businesswire.comRegional Health Properties, Inc. and SunLink Health Systems, Inc. ...August 4, 2025 | gurufocus.comSunLink Health Systems, Inc. Adjourns Special Meeting Until August 4, 2025 and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger With Regional Health Properties, Inc. by August 3, 2025 at 11:59 PM EDTJuly 29, 2025 | businesswire.comA Closer Look at SunLink’s (SSY) Special DividendJuly 26, 2025 | msn.comSunlink Health Systems Receives NYSE American Deficiency NoticeJuly 26, 2025 | theglobeandmail.comSunLink Health Systems updates on planned special cash dividendJuly 24, 2025 | msn.comSunLink Health Systems, Inc. provides an Update on Proxy Voting for the Proposed Merger with Regional Health Properties, Inc. and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger by July 28, 2025 at 11:59 PM EDTJuly 24, 2025 | businesswire.comSunLink Health Systems, Inc. Provides Update on Special Cash Dividend Scheduled to Be Paid Prior to SunLink's Proposed Merger with Regional Health Properties, Inc.July 24, 2025 | businesswire.comSunLink Health Systems, Inc Declares Special Cash Dividend Prior to with the Proposed Merger with Regional Health Properties, Inc.July 21, 2025 | businesswire.comSunLink Health Systems Declares 10c Special DivJuly 19, 2025 | marketwatch.comSunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing ... - MorningstarJuly 8, 2025 | morningstar.comMSunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing StandardsJuly 7, 2025 | businesswire.comSunlink Health Systems Extends Merger Agreement DeadlineJune 23, 2025 | tipranks.comSunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter ResultsMay 13, 2025 | businesswire.comREGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTIONApril 15, 2025 | markets.businessinsider.comSunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter ResultsFebruary 12, 2025 | businesswire.comRegional Health Properties to merge with Sunlink Health SystemsJanuary 8, 2025 | mcknightsseniorliving.comMRegional Health, SunLink Health to merge in all-stock transactionJanuary 7, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGRST, MGRX, SSY, and BICX Company DescriptionsBiocorrx OTCMKTS:BICX$0.35 0.00 (0.00%) As of 08/22/2025BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.Ethema Health OTCMKTS:GRST$0.0003 0.00 (0.00%) As of 08/22/2025Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.Mangoceuticals NASDAQ:MGRX$1.73 +0.07 (+4.22%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$1.63 -0.10 (-5.84%) As of 08/22/2025 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.SunLink Health Systems NYSE:SSY$1.12 +0.16 (+16.56%) Closing price 08/14/2025Extended Trading$1.12 0.00 (0.00%) As of 08/14/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.